>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Johnson & Johnson Innovation - JJDC, Inc. Buys Pulmonx Corp, Sells Provention Bio Inc, Genocea Biosciences Inc

February 09, 2021 | About:

Investment company Johnson & Johnson Innovation - JJDC, Inc. (Current Portfolio) buys Pulmonx Corp, sells Provention Bio Inc, Genocea Biosciences Inc during the 3-months ended 2020Q4, according to the most recent filings of the investment company, Johnson & Johnson Innovation - JJDC, Inc.. As of 2020Q4, Johnson & Johnson Innovation - JJDC, Inc. owns 14 stocks with a total value of $766 million. These are the details of the buys and sells.

For the details of Johnson & Johnson Innovation - JJDC, Inc.'s stock buys and sells, go to https://www.gurufocus.com/guru/johnson+%26+johnson+innovation+-+jjdc%2C+inc./current-portfolio/portfolio

These are the top 5 holdings of Johnson & Johnson Innovation - JJDC, Inc.
  1. Fate Therapeutics Inc (FATE) - 3,379,064 shares, 40.11% of the total portfolio.
  2. Arrowhead Pharmaceuticals Inc (ARWR) - 3,260,869 shares, 32.66% of the total portfolio.
  3. Protagonist Therapeutics Inc (PTGX) - 2,449,183 shares, 6.44% of the total portfolio.
  4. Legend Biotech Corp (LEGN) - 1,629,173 shares, 5.99% of the total portfolio.
  5. MeiraGTx Holdings PLC (MGTX) - 2,898,550 shares, 5.73% of the total portfolio.
New Purchase: Pulmonx Corp (LUNG)

Johnson & Johnson Innovation - JJDC, Inc. initiated holding in Pulmonx Corp. The purchase prices were between $41.35 and $69.02, with an estimated average price of $49.13. The stock is now traded at around $60.010000. The impact to a portfolio due to this purchase was 0.05%. The holding were 5,639 shares as of 2020-12-31.

Sold Out: Provention Bio Inc (PRVB)

Johnson & Johnson Innovation - JJDC, Inc. sold out a holding in Provention Bio Inc. The sale prices were between $11.79 and $18.94, with an estimated average price of $15.01.

Sold Out: Genocea Biosciences Inc (GNCA)

Johnson & Johnson Innovation - JJDC, Inc. sold out a holding in Genocea Biosciences Inc. The sale prices were between $1.91 and $2.67, with an estimated average price of $2.28.



Here is the complete portfolio of Johnson & Johnson Innovation - JJDC, Inc.. Also check out:

1. Johnson & Johnson Innovation - JJDC, Inc.'s Undervalued Stocks
2. Johnson & Johnson Innovation - JJDC, Inc.'s Top Growth Companies, and
3. Johnson & Johnson Innovation - JJDC, Inc.'s High Yield stocks
4. Stocks that Johnson & Johnson Innovation - JJDC, Inc. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)